SEC 13F Intelligence

Rhenman & Partners Asset Management AB / TMO

Rhenman & Partners Asset Management AB’s Thermo Fisher Scientific Inc Position

Does Rhenman & Partners Asset Management AB own Thermo Fisher Scientific Inc (TMO)? Yes — 41.3K shares worth $20M (+2.51% of its 13F portfolio) as of Q1 2026, up from 33.6K shares the prior filed quarter.

Position Value
$20M
Q1 2026
Shares
41.3K
% of Portfolio
+2.51%
Quarters Held
29
currently held

Position History TMO

Reported value by quarter
Q4 ’18: $7MQ4 ’18Q1 ’19: $8MQ2 ’19: $9MQ3 ’19: $11MQ1 ’20: $5MQ1 ’20Q2 ’20: $7MQ3 ’20: $13MQ4 ’20: $13MQ1 ’21: $21MQ1 ’21Q2 ’21: $25MQ3 ’21: $34MQ4 ’21: $29MQ1 ’22: $14MQ1 ’22Q2 ’22: $20MQ3 ’22: $27MQ4 ’22: $22MQ1 ’23: $23MQ1 ’23Q2 ’23: $260,875Q3 ’23: $253,085Q4 ’23: $18MQ1 ’24: $8MQ1 ’24Q2 ’24: $13MQ3 ’24: $16MQ4 ’24: $8MQ1 ’25: $6MQ1 ’25Q2 ’25: $5MQ3 ’25: $15MQ4 ’25: $19MQ1 ’26: $20MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202641.3K$20M+2.51%
Q4 202533.6K$19M+1.82%
Q3 202530.0K$15M+1.61%
Q2 202511.1K$5M+0.57%
Q1 202512.6K$6M+0.72%
Q4 202415.6K$8M+0.84%
Q3 202425.1K$16M+1.26%
Q2 202424.0K$13M+1.27%
Q1 202413.0K$8M+0.72%
Q4 202333.5K$18M+1.78%
Q3 2023500$253,085+0.03%
Q2 2023500$260,875+0.03%
Q1 202341.0K$23M+2.53%
Q4 202240.0K$22M+2.30%
Q3 202252.5K$27M+2.83%
Q2 202237.1K$20M+2.29%
Q1 202223.8K$14M+1.38%
Q4 202144.0K$29M+1.95%
Q3 202160.0K$34M+2.41%
Q2 202150.0K$25M+1.71%
Q1 202145.0K$21M+1.43%
Q4 202027.4K$13M+1.04%
Q3 202030.0K$13M+1.18%
Q2 202019.0K$7M+0.74%
Q1 202019.0K$5M+0.75%
Q3 201938.0K$11M+1.39%
Q2 201929.8K$9M+0.96%
Q1 201930.0K$8M+0.96%
Q4 201830.0K$7M+0.77%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rhenman & Partners Asset Management AB’s full portfolio or all institutional holders of TMO.